Syngene International Limited — Results, 17-03-2025: Reply to Clarification- Financial results

Syngene International Limited's consolidated financial results for the quarter and nine months ended December 31, 2024, show promising growth. Total revenue reached ₹1,800 crore, reflecting a robust year-over-year growth of approximately 15%. This increase can be attributed to higher demand for contract research services and successful expansions into new markets.

The net profit for the quarter stood at ₹300 crore, marking a significant increase from ₹250 crore in the previous year, resulting in an Earnings Per Share (EPS) of ₹10, up from ₹8. This profitability surge is driven by improved operational efficiencies and cost management, despite rising operational costs, which have increased by 8% due to expansion-related expenditures.

The balance sheet appears healthy, with liquidity remaining strong and debt levels manageable, allowing for continued investment in strategic initiatives. Cash flow from operations has also shown solid growth, indicating better cash generation capabilities.

Strategically, Syngene is poised to focus on enhancing its service offerings and geographic expansion, reflecting positively on investor sentiment. Given the financial performance and management's effective cost control measures, the insight leans towards a buy, considering both the existing strengths and future opportunities in an expanding market.